Exposome Assessment and Intervention in Hypersensitivity Pneumonitis
Not Applicable
Recruiting
- Conditions
- Hypersensitivity Pneumonitis
- Registration Number
- JPRN-UMIN000051813
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Minors Patients who are judged by the principal investigator/researcher to be ineligible for participation in the study Patients for whom respiratory function tests cannot be performed Use of certain doses of steroids, cyclosporine A, or tacrolimus at doses greater than 10 mg/day of prednisolone equivalent within 4 weeks prior to screening and planned during the study period Pregnancy or planned pregnancy during the study period Patients who refused to participate in the study Patients who are smoking at the time of inclusion Patients who have no air conditioning in their residence Patients who plan to move within 1 year or relocate for more than 4 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in change in environmental antigen levels between the two groups from the start of the study to 52 weeks Difference in change in effort lung capacity (FVC) and %FVC between the two groups from the start of the study to 52 weeks
- Secondary Outcome Measures
Name Time Method